Tag Archive for: Allergan

Former Global Pharmacovigilance and Clinical Safety Physician Otsuka Pharmaceuticals

Chris Stein, MD, PhD, was recruited by Life Science Partner to serve as Director, Medical Safety Physician for Allergan where he will oversee Pharmacovigilance for Allergan’s CNS drug portfolio.

In his previous role at Otsuka, Stein partnered with safety physicians at Bristol Myers Squibb to co-market the block buster drug, Abilify, and formulate a regulatory compliance strategy and risk management plan while providing signal evaluation and drug safety reporting.

“Intelligent, articulate and passionate about pharmacovigilance, Stein will be able to hit the ground running in his CNS role for Allergan’s pharmacovigilance team,” states Tom Callaway, MD, Founder and President of Life Science Partner. “He brings exceptional analytical and writing skills to be a great addition to the team.”

Chris Stein earned his Bachelor of Science Degree in Biology and Computer Science in 1984 from the Southwest Missouri State University. He completed his MD and PhD from the St. Louis University School of Medicine and his MPH from the University of Kentucky College of Public Health.

Former Senior Director, Global Safety Officer at The Medicines Company

Life Science Partner recruited Yanshan Ma, MD, PhD, to become Senior Director, Medical Safety Physician, Internal Medicine and Infectious Diseases for Allergan. 

In her new role Dr. Ma will be responsible for the group’s safety strategy, pharmacovigilance and medical risk management.

Dr. Ma joins Allergan after leading a cross-functional safety management team at The Medicines Company where she was responsible for ensuring accurate safety evaluation and signal detection.  She’s been a key member in the growth of The Medicines Company.

“Dr. Ma has hands-on leadership experience of both small groups and matrix organizations of physicians and safety scientists,” commented Tom Callaway, MD, Founder and President of Life Science Partner.  “She has the work ethic and pharmacovigilence knowledge that will fit nicely with the entrepreneurial environment of Allergan.”

Dr. Ma earned her PhD in Biochemistry from East Tennessee State University’s James E. Quillen College of Medicine and her MD from Sun Yat-sen University of Medical Sciences in China.

Former Global Head of Safety Surveillance for Amgen

Life Science Partner recruited Andre Daniels, MBChB, Executive Director, Pharmacovigilance at Amgen to become Vice President, Head of Medical Safety Physicians at Allergan.

In his new role, Daniels will lead a team of physician executives to support the four key commercial franchises and their pipeline of innovative products.

“Daniels has built safety organizations with global portfolios as diverse as oncology, metabolic diseases, and virology,” stated Tom Callaway, MD, MBA, President of Life Science Partner.

During his first eight years at Amgen, Daniels led the Global Head of Safety Surveillance team with accountability for monitoring clinical safety and all post-marketing safety for all Amgen products.

Prior to his roles at Amgen, Daniels was the Director of Medical Review, Global Drug Safety for Gilead Science.  He began his pharmaceutical career at Pfizer and he became the Global Therapeutic Safety Head, supervising a global team for endocrine, metabolic, and cardiovascular product development.

Originally from South Africa, Daniels earned his MBChB from the University of Cape Town. He earned his diploma in Clinical Epidemiology and Biostatistics as well as his Master in Medical Science (Clinical Epidemiology) from the University of Newcastle, Australia.

Learn More About Life Science Partner

Click button below to learn more about how we recruit Chief Executives:

Former Director, Corporate Compliance & Global Data Privacy at Bausch & Lomb

Life Science Partner recruited Courtney Barton, an experienced global compliance executive, to become Director, Corporate Compliance for Allergan Medical.

In her new role, Barton will be responsible for leading compliance with CIA directives and developing Allergan’s compliance policies for the $1.4B medical device businesses.  Barton will report to the Vice President and Deputy Director Wes Porter.  Porter was recruited by Life Science Partner to Allergan in 2012.

Prior to her new position at Allergan, Barton spent much of her career at Bausch & Lomb where she played a key role in building and maintaining the Company’s current Compliance Program.

Barton earned Bachelor of Arts in International Relations and Political Science from Syracuse University.

Life Science Partner recruits former Associate Director, US Pharmaceuticals Compliance and Ethics for Bristol-Myers Squibb

Allergan, Inc. is a technology-driven, multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices in the areas of eye care, neurosciences, medical dermatology and urologics. The company is best known for its Botox franchise.

Tina Webb, an experienced pharmaceutical compliance executive, has joined Allergan as the Director of Business Compliance, Pharmaceuticals. 

In this role, she will be responsible for providing advice and leading efforts regarding Allergan’s compliance policies and procedures for the pharmaceutical business within the United States.  She will work with the sales force to build communication strategies and messages that are effective but consistent with the product’s approved uses – and create solutions that enhance physician customer relations with the CIA guidelines.

In her previous role at Bristol-Myers Squibb, Webb was responsible for developing, overseeing and maintaining the Company’s US Compliance and Ethics program.  She successfully brought automation and systemization of the compliance program that allowed the sales and marketing organization to function more effectively while in compliance.

“Tina has an analytical and legal approach to compliance combined with a sales-oriented personality,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “Her broad experience in creating and implementing compliance programs for US Sales and Marketing organizations will be a great asset for the Allergan Compliance team.”

Webb earned her degree from Rutgers University in New Brunswick, NJ.

About Life Science Partner

Life Science Partner’s high-quality executive, research and professional placement services target the very specific needs of life sciences and healthcare organizations. We identify and recruit the brightest talent in the biotechnology, pharmaceutical, medical device, academic and healthcare services fields.  Our combined scientific backgrounds and senior management experience give us the scientific literacy and business knowledge to help us better understand challenges, refine requirements and work more effectively with our life science clients.

Life Science Partner recruits Vice President of Ethics and Compliance at CareFusion

Life Science Partner announces the recruitment of Wes Porter, a senior compliance executive and attorney, to become Vice President, Deputy Compliance Officer at Allergan Inc. 

Best known for its Botox franchise, Allergan is a technology-driven, multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices in the areas of eye care, neurosciences, medical dermatology and urologics.

In Porter’s previous role at CareFusion, a leading global medical technology company headquartered in San Diego, he helped build the de novo compliance organization for the $4 billion revenue spin off from Cardinal Health.  He was most recently responsible for global compliance programs for both the Procedural Solutions and Medical Systems operating segments for the company.  Prior to joining CareFusion, Porter served as the global compliance lawyer for all four Smith & Nephew business units, managing complex internal and external investigations for the company.

“Wes is smart, aggressive, and has worked diligently to build teams as evidenced by his success in career progression and scope of responsibility,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “He leads a team that Life Science Partner has helped recruit in partnership with Rose-Karen Swanson, Chief Compliance Officer, to transform the business as required by the Company’s 2010 Compliance Integrity Agreement.”

Porter earned his degree in History at Occidental College in Los Angeles, CA, followed by earning his Masters in Health Administration and Juris Doctorate from St. Louis University in St. Louis, MO.

About Life Science Partner

Life Science Partner’s high-quality executive, research and professional placement services target the very specific needs of life sciences and healthcare organizations. We identify and recruit the brightest talent in the biotechnology, pharmaceutical, medical device, academic and healthcare services fields.  Our combined scientific backgrounds and senior management experience give us the scientific literacy and business knowledge to help us better understand challenges, refine requirements and work more effectively with our life science clients.

Life Science Partner recruits former Assistant Director, Global Medical Publishing at Abbott Laboratories

Life Science Partner announces the recruitment of William Glass, PhD, an experienced global medical affairs executive, to Allergan, Inc., to become Senior Director, Publications, Global Medical Affairs for the company.

Allergan is a technology-driven, multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices in the areas of eye care, neurosciences, medical dermatology and urology.

Working with the physician leaders at Abbott Laboratories, Glass oversaw the development and execution of the global publication strategy across therapeutic areas utilizing the considerable scientific data generated by Abbott clinical trials.  Prior to joining Abbott, Glass was a Senior Research Scientist at Centocor Research and Development in Radnor, Pennsylvania.

“Glass has a well-balanced background in publication strategy and tactical delivery,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “His high energy, solid influencing skills and experience in utilizing data-driven metrics will serve Allergan well in its mission to educate physicians and healthcare professionals about important new therapies that improve people’s lives.”

Glass earned his Bachelor of Science in Biology from San Diego University and then received PhD from University of California, Irvine. He completed his Post Doctoral Fellowship at NIAID in Bethesda, Maryland.

Life Science Partner recruits former Director of Global Compliance Program at Mylan Pharmaceuticals

Life Science Partner announces the recruitment of Nancy Grygiel, an experienced global compliance executive, to Allergan, Inc. to become Senior Director, Corporate Compliance, International for the company.

Allergan is a technology-driven, multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices in the areas of eye care, neurosciences, medical dermatology and urologics.

In Grygiel’s previous role at Mylan Pharmaceuticals, a Pennsylvania-based company developing generic and specialty pharmaceuticals, she was responsible for overseeing the global compliance program operations across North American, Asia Pacific, Europe and Middle East, and India and China.

Prior to joining Mylan, Grygiel practiced as an International Business Transactions and Immigration Specialist at the Law Offices of Paul S. Haar in Washington, DC.

“Nancy is an articulate and passionate compliance officer with a personality and communication skills that allow her to succeed in four languages,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “Her vast international experience and global compliance background will serve Allergan well in its mission to commercialize important new therapies that make a real difference.”

Grygiel earned her degree in Legal Studies from the Universidad De Buenos, Aires and then received her Master of Law Degree from Georgetown Law Center.